Browsing eNauka

Browsing by Project Shire

Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)TypeМ-cat.
2021Cardiovascular Safety of Anagrelide Hydrochloride versus Hydroxyurea in Essential Thrombocythaemia (✓)Gotić, Mirjana D.  ; Egyed, Miklos; Gercheva, Liana; Warzocha, Krzysztof; Kvasnicka, Hans Michael; Achenbach, Heinrich; Wu, JingyangArticle
22M22
2017Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practiceBen-Horin, Shomron; ...; Protic, Marijana B; ...; (broj, koautora 17)Article
22M22
2024Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders DatabaseMohsenian, Samin; ...; Mikovic, Danijela; Saracevic, Marko; ...; (broj, koautora 40)Article
21M21
2021Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT IIReinisch, Walter; ...; Tarabar, Dino K; ...; (broj, koautora 18)Article
21M21
2021Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II StudyD'Haens, Geert R; ...; Tarabar, Dino K; ...; (broj, koautora 17)Article
21M21
2023Self-Harm in Children and Adolescents Who Presented at Emergency Units During the COVID-19 Pandemic: An International Retrospective Cohort StudyWong, Ben Hoi-Ching; ...; Stevanovic, Dejan S; ...; (broj, koautora 65)Article
21aM21a
2018Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2 (✓)Tiede, Andreas; Janic, Dragana M  ; Ozelo, M; Santagostino, E; Korsholm, Lars; Matytsina, Irina; Lentz, SRConference Paper
Mp. category will be shown later